Answers are grounded in this paper and cite their sources.
This review highlights gliclazide's glycemic and extraglycemic effects in type 2 diabetes, suggesting significant health advantages.
The increasing prevalence of type 2 diabetes mellitus (T2DM) and the associated challenges in treatment are a cause of concern worldwide. Gliclazide is an oral antidiabetes drug used in the treatment of T2DM. It is a second-generation sulphonylurea (SU) which controls blood glucose levels and offers additional benefits. It is distinct from other SUs in terms of its molecular and structural properties. Early aggressive management of blood glucose in diabetes has been shown to provide advantages for micro- and macrovascular complications. Hence, this review is intended to discuss the glycemic and extraglycemic effects of gliclazide.
No takes yet. Share an insight, caveat, or question.
Bishnoi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: